Using Outreach to Improve Colorectal Cancer Screening

Michael Pignone^{1

2}, David P Miller Jr³

Affiliations

¹ Department of Medicine, Dell Medical School, University of Texas, Austin.
² LiveStrong Cancer Institute, Austin, Texas.
³ Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina.

Editorial

Michael Pignone et al. JAMA. 2017.

. 2017 Sep 5;318(9):799-800.

doi: 10.1001/jama.2017.10606.

Michael Pignone^{1

2}, David P Miller Jr³

¹ Department of Medicine, Dell Medical School, University of Texas, Austin.
² LiveStrong Cancer Institute, Austin, Texas.
³ Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina.

No abstract available

Comment on

Effect of Physician Notification Regarding Nonadherence to Colorectal Cancer Screening on Patient Participation in Fecal Immunochemical Test Cancer Screening: A Randomized Clinical Trial.
Rat C, Pogu C, Le Donné D, Latour C, Bianco G, Nanin F, Cowppli-Bony A, Gaultier A, Nguyen JM. Rat C, et al. JAMA. 2017 Sep 5;318(9):816-824. doi: 10.1001/jama.2017.11387. JAMA. 2017. PMID: 28873160 Free PMC article. Clinical Trial.
Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
Singal AG, Gupta S, Skinner CS, Ahn C, Santini NO, Agrawal D, Mayorga CA, Murphy C, Tiro JA, McCallister K, Sanders JM, Bishop WP, Loewen AC, Halm EA. Singal AG, et al. JAMA. 2017 Sep 5;318(9):806-815. doi: 10.1001/jama.2017.11389. JAMA. 2017. PMID: 28873161 Free PMC article. Clinical Trial.